MENU
+Compare
JDOC
ETF ticker: NASDAQ
AS OF
Sep 24, 03:28 PM (EDT)
Price
$51.17
Change
-$0.30 (-0.58%)
Net Assets
7.69M

JDOC stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Health
JDOC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for JDOC with price predictions
Sep 23, 2025

JDOC in upward trend: 10-day moving average moved above 50-day moving average on August 22, 2025

The 10-day moving average for JDOC crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

JDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 96 cases where JDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for JDOC moved out of overbought territory on September 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on JDOC as a result. In of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for JDOC turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Amgen (NASDAQ:AMGN), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT).

Industry description

The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Market Cap

The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 78.06B. The market cap for tickers in the group ranges from 1.44B to 665.04B. LLY holds the highest valuation in this group at 665.04B. The lowest valued company is ROG at 1.44B.

High and low price notable news

The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was -0%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was -3%. MCK experienced the highest price growth at 10%, while DXCM experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was 4% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 67
Price Growth Rating: 56
SMR Rating: 62
Profit Risk Rating: 68
Seasonality Score: -33 (-100 ... +100)
View a ticker or compare two or three
JDOC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
J.P. Morgan Exchange-Traded Fund Trust270 Park AvenueNew York
Phone
(800) 480-4111
Web
N/A